Peptides – Talk Bio

Merck inks $493M biobucks deal to use Cyprumed’s tech to create oral peptides

1 week ago talkbio0Tagged biobucks, Cyprumed, Merck, Peptides

Cyprumed, Merck, biobucks, Peptides

PRISM BioLab and Elix Collaborate to Revolutionize AI-Driven Drug Discovery with Peptide Mimetics

1 week ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, Drug Discovery, Efficiency, Elix, mimetics, PepMetics, Peptides, pharmaceutical innovation, PRISM BioLab, Protein-Protein Interaction, small molecule inhibitors

PRISM BioLab , Elix , AI drug discovery , Peptide mimetics , Protein-protein interactions , PepMetics® , Small molecule inhibitors , Drug discovery efficiency , Pharmaceutical innovation

AI-Driven Discovery Unveils Novel Antimicrobial Proteins Effective Against Bacterial and Fungal Infections in Mice

2 months ago talkbio0Tagged Artificial Intelligence, Bacterial Infections, Drug Discovery, in vivo studies, Microbicides, Mycoses, Peptides, protein compounds

Artificial intelligence, protein compounds, antimicrobial peptides, drug discovery, bacterial infections, fungal infections, in vivo studies

AbbVie Expands Immunology Pipeline with $200M Acquisition of Nimble Therapeutics

4 months ago talkbio0Tagged AbbVie, Autoimmune Diseases, IL23R gene, Immunology, Inhibitor, Nimble, Peptides, Psoriasis

AbbVie, Nimble Therapeutics, Immunology, Psoriasis, Autoimmune Diseases, IL23R Inhibitor, Peptide Therapeutics

Versant Ventures Launches Pep2Tango Therapeutics with Revolutionary Tetra-Receptor Agonist Approach for Obesity Treatment

5 months ago talkbio0Tagged Amylin, Calcitonin Receptor, GIP/, GLP-1, muscle mass, Next, Next-generation weight loss therapies, Obesity, Pep2Tango, Peptides, Tetra-receptor, Ventures, Versant

Obesity treatment, Tetra-receptor agonist peptides, GLP-1/ GIP/ amylin/ and calcitonin receptors, Muscle mass preservation, Next-generation weight loss therapies, Versant Ventures, Pep2Tango Therapeutics Inc.